NOTV

Inotiv, Inc. NASDAQ

Healthcare ·Medical - Diagnostics & Research ·US · inotivco.com

$0.32

Mkt Cap $10.9M

52w Low $0.22 3.1% of range 52w High $3.32

50d MA $0.31 200d MA $0.94

P/E (TTM) -0.1x

EV/EBITDA 21.4x

P/B 0.1x

Debt/Equity 3.7x

ROE -63.6%

P/FCF -1.7x

RSI (14) —

ATR (14) —

Beta 4.08

50d MA $0.31

200d MA $0.94

Avg Volume 693.9K

About

Inotiv, Inc. provides drug discovery and development services to the pharmaceutical, chemical, and medical device industries; and sells analytical instruments to the pharmaceutical development and contract research industries. It operates through two segments, Contract Research Services and Research Products. The Contract Research Services segment offers screening and pharmacological testing, nonc… Inotiv, Inc. provides drug discovery and development services to the pharmaceutical, chemical, and medical device industries; and sells analytical instruments to the pharmaceutical development and contract research industries. It operates through two segments, Contract Research Services and Research Products. The Contract Research Services segment offers screening and pharmacological testing, nonclinical safety testing, formulation development, regulatory compliance, and quality control testing services. This segment provides analytical method development and validation; drug metabolism, bioanalysis, and pharmacokinetics testing to identify and measure drug and metabolite concentrations in complex biological matrices; in vivo sampling services for the continuous monitoring of chemical changes in life; stability testing to ensure the integrity of various solutions used in nonclinical and clinical studies, and post-study analyses; non-clinical toxicology and pathology services; and climate-controlled archiving services for its customers' data and samples. The Research Products segment designs, develops, manufactures, and markets in vivo sampling systems and accessories, including disposables, training, and systems qualification; physiology monitoring tools; liquid chromatography and electrochemistry instruments platforms; analytical products comprising liquid chromatographic and electrochemical instruments with associated accessories; and in vivo sampling products consisting of Culex family of automated in vivo sampling and dosing instruments. The company operates in the United States, rest of North America, the Pacific Rim, Europe, and internationally. It has an agreement with BioVaxys to conduct preclinical toxicity studies for its Covid-T Immunodiagnostic program. The company was formerly known as Bioanalytical Systems, Inc. and changed its name to Inotiv, Inc. in March 2021. Inotiv, Inc. was founded in 1974 and is headquartered in West Lafayette, Indiana.

Recent Earnings

Date	Time	Est	Rptd	Surp	Base	Gap%	D1%	D2%	D3%	D4%	D5%	Guide ▲★
Feb 9, 2026	BMO	-0.64	-0.72	-12.9%	0.36	+2.4%	-7.9%	-13.1%	-19.7%	-21.2%	-19.2%	—
Dec 3, 2025	BMO	-0.08	-0.14	-75.0%	0.94	-7.7%	-6.5%	-14.1%	-11.7%	-9.7%	-10.5%	—
Aug 6, 2025	BMO	-0.15	-0.12	+20.0%	2.19	+0.5%	-10.5%	-16.4%	-14.6%	-8.7%	-9.6%	—
May 7, 2025	BMO	-0.24	-0.18	+25.0%	2.01	+8.5%	+10.4%	-2.5%	+9.0%	+4.5%	+1.5%	—
Feb 5, 2025	BMO	-0.42	-0.42	+0.0%	4.18	+4.1%	-6.2%	-16.0%	-1.9%	-8.9%	-10.5%	—
Dec 3, 2024	BMO	-0.91	-0.16	+82.4%	4.19	-1.2%	-6.2%	-4.1%	-9.3%	-6.4%	+15.5%	—
Aug 8, 2024	BMO	-0.09	-0.20	-122.2%	1.68	-7.1%	-0.6%	-6.5%	-10.1%	-8.9%	-8.9%	—
May 15, 2024	BMO	0.05	-0.29	-680.0%	2.24	-4.9%	-4.5%	-13.8%	-17.9%	-5.4%	-8.9%	—
Feb 7, 2024	BMO	0.07	-0.60	-957.1%	3.68	+9.5%	+16.8%	+34.8%	+47.8%	+40.8%	+55.2%	—
Dec 11, 2023	BMO	0.11	-0.29	-363.6%	3.03	+5.0%	-15.8%	-8.9%	+2.3%	+3.6%	+14.5%	—
Aug 10, 2023	BMO	-0.10	0.07	+170.0%	6.40	-13.0%	-35.6%	-36.2%	-40.6%	-45.6%	-46.1%	—
May 11, 2023	BMO	-0.16	-0.34	-112.5%	6.56	-2.9%	-11.1%	-5.0%	-4.3%	-3.2%	-1.7%	—

Recent Analyst Ratings

Date	Firm	Action	Grade	Target	Base	Open	Gap%	D1%	D2%	D3%	D4%	D5%
Feb 10	Lake Street	Maintains	Buy → Buy	—	$0.36	$0.37	+2.4%	-7.9%	-13.1%	-19.7%	-21.2%	-19.2%
Dec 4	Lake Street	Maintains	Buy → Buy	—	$0.94	$0.87	-7.7%	-6.5%	-14.1%	-11.7%	-9.7%	-10.5%
May 8	Lake Street	Maintains	Buy → Buy	—	$2.01	$2.18	+8.5%	+10.4%	-2.5%	+9.0%	+4.5%	+1.5%
Sep 30	Lake Street	Upgrade	Hold → Buy	—	$1.58	$1.68	+6.3%	+7.6%	+15.8%	+22.2%	+24.7%	+22.2%
May 16	Craig-Hallum	Maintains	Buy → Buy	—	$2.24	$2.13	-4.9%	-4.5%	-13.8%	-17.9%	-5.4%	-8.9%
May 16	Lake Street	Downgrade	Buy → Hold	—	$2.24	$2.13	-4.9%	-4.5%	-13.8%	-17.9%	-5.4%	-8.9%
May 14	Jefferies	Downgrade	Buy → Hold	—	$4.17	$2.84	-31.9%	-49.2%	-46.3%	-48.7%	-53.7%	-55.9%
Feb 9	Jefferies	Upgrade	Hold → Buy	—	$4.30	$4.80	+11.6%	+15.3%	+26.5%	+20.5%	+32.8%	+29.5%
Dec 12	Craig-Hallum	Maintains	Buy → Buy	—	$3.03	$3.18	+5.0%	-15.8%	-8.9%	+2.3%	+3.6%	+14.5%
Jan 19	Jefferies	Downgrade	Buy → Hold	—	$7.57	$7.20	-4.9%	-17.3%	-12.8%	-6.5%	-10.3%	-9.9%
Jan 11	Lake Street	Upgrade	Hold → Buy	—	$5.59	$6.27	+12.2%	+31.3%	+36.7%	+45.3%	+54.6%	+35.4%
Nov 18	Lake Street	Downgrade	Buy → Hold	—	$6.82	$6.39	-6.3%	-15.7%	-2.8%	-2.6%	-2.8%	+1.8%
Oct 4	Jefferies	Maintains	Buy → Buy	—	$17.74	$18.94	+6.8%	+10.5%	+17.9%	+9.4%	+9.1%	+9.9%
Aug 11	Lake Street	Maintains	Buy → Buy	—	$20.73	$24.30	+17.2%	+15.8%	+26.2%	+24.1%	+23.5%	+20.5%
Jan 31	Lake Street	Maintains	Buy → Buy	—	$27.63	$28.01	+1.4%	+15.8%	+11.3%	+20.2%	+18.2%	+23.3%
Sep 20	Craig-Hallum	Maintains	Buy → Buy	—	$35.09	$35.09	+0.0%	+4.9%	+42.3%	-2.8%	-3.9%	-2.2%